North America Soft Tissue Repair Market Segments and Growth by 2028

The North America soft tissue repair market is expected to grow from US$ 3,806.87 million in 2021 to US$ 5,846.24 million by 2028; it is estimated to grow at a CAGR of 6.3% from 2021 to 2028.

Playing sports benefits adolescents physiologically, psychologically, and socially. It helps improve health conditions, self-esteem, and social interactions, alongside decreasing the risk of depression. However, sports practice is inevitably linked with the occurrence of injuries. In the US, alone, 3.5 million youth under the age of 15 receive medical care every year for injuries caused during sports practice. In addition, two-thirds of these injuries required care in emergency units. According to estimates by Stanford Children’s Health, in 2019, ~30 million children participated in sports and other recreational activities in the US. Also, ~3.5 million injuries are reported in the country each year, and ~75,000 children of age 14 and below are treated for these injuries. This high participation rate of children in sports, coupled with an increase in injuries, is creating demand for sports medicines. Contact sports such as basketball and football, involving contact and collision, possess a higher rate of sports injuries. This leads to severe injuries to joints, bones, and tendons, and other soft tissues. Such injuries require emergency treatment or even surgical procedures. As per Spinal Cord, Inc., ~170,000 children with basketball-related injuries were treated in hospital emergency rooms. Thus, the rising prevalence of sports injuries is contributing to the soft tissue repair market growth.

In North America, the US and Mexico witnessed a spike in COVID-19 cases, which has compelled the governments to restrict business activities to prevent the spread of the virus. At present, all the efforts and resources are being put toward mitigating this crisis, which has slowed down other economic activities. The COVID-19 outbreak has had a significant impact on all aspects of orthopedic care and practice. The outbreak pandemic has negatively affected activities related to the outpatient clinic, emergency and elective surgery, rehabilitation, resident training, personnel management, personal protective equipment use, telemedicine, and all sub-specialties of orthopedics. Therefore, the crisis is restraining the growth of the soft tissue repair market in North America.

With the new advancements and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America soft tissue repair market. Technological developments in regenerative medicine and new product launches by North America and local players are likely to be instrumental in the future growth of the soft tissue repair market players. Cutting-edge technologies offer competitive advantages to companies. In July 2021, B.D. acquired Tepha, Inc., a leading developer and manufacturer of proprietary resorbable polymer technology. The poly 4-hydroxybutyric acid (P4HB) technology platform, Tepha's proprietary resorbable polymer, provides additional innovation potential that can accelerate the growth of B.D.'s surgical mesh portfolio focused on new areas of soft tissue repair, reconstruction, and regeneration. In April 2020, In2Bones launched ClearGuard LE Endoscopic Soft Tissue Release System for the US-based orthopedic and podiatric specialists to treat a variety of foot problems. The company is a US-based designer, manufacturer, and distributor of medical devices for treating disorders and injuries. The ClearGuard LE Endoscopic Soft Tissue Release System gives orthopedic and podiatric specialists an easy-to-use, repeatable, and cost-effective system for high-volume lower extremity soft tissue surgeries on plantar fascia, gastrocnemius, tarsal tunnel, and Morton’s neuroma. Furthermore, in February 2020, Aroa Biosurgery, a privately held soft-tissue repair company, launched Myriad, a new product for soft tissue repair and reconstruction in the US market. The release of Myriad marks the next step of growth for Aroa and its commitment to providing leading solutions that are accessible for both clinicians and their patients.
 

North America Soft Tissue Repair Market Segmentation

North America Soft Tissue Repair Market – By Product

• Fixation Instruments
• Tissue Mesh/Patch

North America Soft Tissue Repair Market – By Application

• Orthopedic Repair
• Hernia Repair
• Breast Reconstruction
• Pelvic and Vaginal Prolapse Repair
• Skin Repair
• Dental Repair
• Dural Repair
• Others

North America Soft Tissue Repair Market – By Country

• US
• Canada
• Mexico

North America Soft Tissue Repair Report Scope